Jiwei Li
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
High body-mass index and multiple myeloma risk: insights from the global burden of disease 2021 study and identification of core target genes.
Journal: Hematology (Amsterdam, Netherlands)
Published: March 11, 2026
Correction: Global trend analysis and risk evolution of asbestos-related ovarian cancer: a population-based study and future prediction (1990-2021).
Journal: Frontiers in public health
Published: January 10, 2026
Clinicopathological Features and Survival Prognosis of Subcutaneous Panniculitis-Like T-Cell Lymphoma: A Population-Based Study from the SEER Database with Supplementary Single-Center Case Validation.
Journal: International journal of general medicine
Published: October 11, 2025
Global trend analysis and risk evolution of asbestos-related ovarian cancer: a population-based study and future prediction (1990-2021).
Journal: Frontiers in public health
Published: September 17, 2025
Global, regional, and national disease burden of lymphoma and leukemia attributable to high body mass index: from 1990 to 2021.
Journal: Frontiers in nutrition
Published: March 13, 2025
The Spatial Proximity of CD8+ FoxP3+PD-1+ Cells to Tumor Cells: A More Accurate Predictor of Immunotherapy Outcomes in Advanced Non-Small-Cell Lung Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: March 07, 2025
New insights into the role of macrophages in cancer immunotherapy.
Journal: Frontiers in immunology
Published: February 03, 2024
Inhibitory effect of PI3Kδ inhibitor idelalisib on proliferation of human myeloid leukemia cells and the reversal effect on drug resistance to adriamycin.
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: January 21, 2021
Clinicopathological Features, Treatment, and Prognosis in Primary Diffuse Large B Cell Lymphoma of the Breast: A Retrospective Study of 46 Patients.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: November 18, 2019
Short-Course Versus Long-Course Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T cell Lymphoma, Nasal Type: A Multicenter Retrospective Study.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: May 02, 2018
Retraction notice to "BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma" [Biochem. Biophys. Res. Commun. 491 (2017) 939-945].
Journal: Biochemical and biophysical research communications
Published: March 14, 2018
Last Updated: 09/26/2026